Still, it remains to be explored whether genetic variation in PNPLA3, particularly rs738409 that is the major genetic modifier of NAFLD (44) and the disease severity (45, 46), has a differential role in the conversion of tributyrin into butanoate. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.